Among the BC molecular subgroups, HER2-positive and triple-negative breast cancer (TNBC) are those most frequently associated with the development of BMs, with a cumulative incidence of 31% and 32%, respectively, while CNS involvement is rarer in the luminal subtype, with a cumulative incidence of 15% [65]. This evidence concerns the gene ERBB2 and breast cancer.